Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million GlobeNewswire October 01, 2025 – Strengthened balance sheet to fully fund development and launch of NXT-41 platform – – Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market – GAITHERSBURG, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) — Elutia Inc. […]